Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
RMD Open|December 31, 2024
Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosusMasanobu Ueno, Shigeru Iwata, Kaoru Yamagata, et al.
Rheumatology (Oxford, England)|November 5, 2024
Predictors of the effectiveness of first-line CTLA4-Ig in patients with RA: the FIRST registryHiroki Kobayashi, Yusuke Miyazaki, Shingo Nakayamada, et al.
RMD Open|January 16, 2026
Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registryMasanobu Ueno, Koshiro Sonomoto, Hiroaki Tanaka, et al.
RMD Open|February 5, 2026
Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registryHidenori Sakai, Koshiro Sonomoto, Shingo Nakayamada, et al.
Rheumatology (Oxford, England)|September 17, 2024
Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registryHidenori Sakai, Yusuke Miyazaki, Shingo Nakayamada, et al.
Rheumatology and Therapy|May 16, 2025
Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid ArthritisAtsushi Nagayasu, Yusuke Miyazaki, Koshiro Sonomoto, et al.
Plos One|May 4, 2016
The Multidisciplinary Swallowing Team Approach Decreases Pneumonia Onset in Acute Stroke PatientsShiro Aoki, Naohisa Hosomi, Junko Hirayama, et al.
Annals of the Rheumatic Diseases|October 4, 2024
Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsivenessSatoshi Kubo, Yusuke Miyazaki, Takahiro Nishino, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsivenessSatoshi Kubo, Yusuke Miyazaki, Takahiro Nishino, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2022
Early B cell factor 4 modulates FAS-mediated apoptosis and promotes cytotoxic function in human immune cellsSatoshi Kubo, Rhea Kataria, Yikun Yao, et al.
Pageof 19